Lördag 21 December | 15:33:16 Europe / Stockholm

Kalender

Tid*
2025-08-28 07:00 Kvartalsrapport 2025-Q2
2025-06-05 N/A Årsstämma
2025-04-10 00:00 Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-19 - Årsstämma
2024-06-06 - X-dag ordinarie utdelning CRNA 0.00 NOK
2024-04-25 - Bokslutskommuniké 2023
2023-10-04 - Split CRNA 30:1
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-22 - Årsstämma
2023-04-21 - X-dag ordinarie utdelning CRNA 0.00 NOK
2023-03-09 - Extra Bolagsstämma 2023
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-20 - Årsstämma
2022-04-07 - X-dag ordinarie utdelning CRNA 0.00 NOK
2022-02-17 - Bokslutskommuniké 2021
2021-11-25 - Extra Bolagsstämma 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-18 - X-dag ordinarie utdelning CRNA 0.00 NOK
2021-03-17 - Årsstämma
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-04-30 - X-dag ordinarie utdelning CRNA 0.00 NOK
2020-04-29 - Årsstämma
2020-03-11 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-09 - Kvartalsrapport 2019-Q1
2019-04-10 - X-dag ordinarie utdelning CRNA 0.00 NOK
2019-04-09 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-01 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-03 - Kvartalsrapport 2018-Q1
2018-04-12 - X-dag ordinarie utdelning CRNA 0.00 NOK
2018-04-11 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-04-05 - Årsstämma
2017-02-16 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-12 - Kvartalsrapport 2016-Q1
2016-04-14 - X-dag ordinarie utdelning CRNA 0.00 NOK
2016-04-13 - Årsstämma
2015-06-23 - X-dag ordinarie utdelning CRNA 0.00 NOK
2015-06-22 - Årsstämma

Beskrivning

LandNorge
ListaOB Match
SektorHälsovård
IndustriBioteknik
Circio Holding är ett läkemedelsbolag. Bolaget specialistkompetens återfinns inom riktad immunterapi som används vid behandling av cancerpatienter. Bolagets verksamhet består av forskning och utveckling och läkemedlen säljs idag under separata varumärken. Ett flertal partnerskap på marknaden har ingåtts för att stärka samarbetet inom utvecklingen av ny immunterapi. Bolaget grundades 2010 och har sitt huvudkontor i Lysaker.
2024-07-08 07:00:00

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Oslo, 8 July 2024: Reference is made to the stock exchange announcements published by Circio Holding ASA (the "Company") on 19 June 2024 regarding the general meeting's approval of the rights issue of between 3,658,000 new shares to 20,732,010 new shares in the Company, at a subscription price of NOK 2.50 per share (the "Offer Shares") to raise gross proceeds of up to approximately NOK 52 million (the "Rights Issue"). In addition, the subscribers in the Rights Issue will be allocated one warrant for every Offer Share allocated to them and paid by them in the Rights Issue (the "Warrants"). Reference is further made to the stock exchange announcement on 24 June 2024 regarding the commencement of the subscription period for the Rights Issue.

The subscription period for the Rights Issue (the "Subscription Period") will expire today, on 8 July 2024 at 16:30 hours (CEST).

Over-subscription and subscription without subscription rights is permitted. However, there can be no assurance that Offer Shares will be allocated for such subscriptions.

Correctly completed Subscription Forms must be received by DNB Markets, a part of DNB Bank ASA, Registrars department (the "Receiving Agent") no later than on 8 July 2024 at 16:30 hours (CEST) at the following address or email address: DNB Markets, a part of DNB Bank ASA, Registrars department by post to Dronning Eufemias gate 30, 0191 Oslo, Norway, or email to retail@dnb.noor in case of online subscriptions, subscriptions must be registered by the expiry of the Subscription Period through the VPS online subscription system by following this link: VPS online subscription (https://investor.vps.no/sc/servlet/no.vps.sc.servlets.SCLogonServlet?ISIN=NO0013261016&TSted=07910&Sig=00ab13963964c58b9e4c00dd957bd2e0ee09ae9b866c769093ec5eccaaeeaf2c).

Subscription Rights that are not used to subscribe for Offer Shares before the expiry of the Subscription Period will have no value and will lapse without compensation to the holder.

For more information, and the complete terms and conditions of the Rights Issue, including the subscription form, please refer to the securities note approved on 18 June 2024 (the "Securities Note" and together with a registration document supplement and summary, approved on 18 June 2024, and a registration document approved on 28 September 2023 and a registration document supplement approved on 8 March 2024 comprises the "Prospectus"). The Prospectus is, subject to applicable local securities laws, available at the websites of the Company, https://www.circio.com/en/rights-issue-2024/

Redeye AB is acting as manager in the Rights Issue (the "Manager") and Advokatfirmaet Thommessen AS is acting as legal counsel to the Company in connection with the Rights Issue.